Effect of tumor necrosis factor inhibitors on risk of cardiovascular disease in patients with axial spondyloarthritis

BACKGROUND: Axial spondyloarthritis (axSpA) is associated with an increased risk of cardiovascular disease. We aimed to evaluate the effect of tumor necrosis factor inhibitors (TNFis) on the risk of cardiovascular disease in patients with axSpA. METHODS: This retrospective study included 450 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Oh Chan, Park, Min-Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190158/
https://www.ncbi.nlm.nih.gov/pubmed/35698171
http://dx.doi.org/10.1186/s13075-022-02836-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190158/
https://www.ncbi.nlm.nih.gov/pubmed/35698171
http://dx.doi.org/10.1186/s13075-022-02836-4

Ejemplares similares